Bimatoprost/Timolol Teva

Medicinal product

(Invented) name

Bimatoprost/Timolol Teva

Active substance (s)

Bimatoprostas/Timololis

Strength

0,3 mg/5 mg/ml

Pharmaceutical form

akių lašai (tirpalas)

Route (s) of administration

vartoti ant akių

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01ED51, Timolol, combinations

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2017-07-27

Date of renewal

2022-04-22

Documents

4112 Pakuotės lapelis 2025 06 25.docx

4112 Bimatoprost_Timolol Teva RPP 2025 06 25.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(3)

Procedure number

NL/H/3809/001/C

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Bimatoprostas	0,3 mg
Timololis	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
97442	83536	1083536	buteliukas	3 ml N1		Receptinis	LT/1/17/4112/001	Tiekiama	-	-	No	-	-	Download
97443	83537	1083537	buteliukas	3 ml N3		Receptinis	LT/1/17/4112/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-04-22	Perregistruotas
2017-07-27	Registruotas